Clinical Trial Detail

NCT ID NCT03614949
Title SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

cervical cancer

Therapies

Atezolizumab

Age Groups: senior adult

No variant requirements are available.